SWOT Analysis for Natco Pharma Ltd.

Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Strong Performer, Under Radar Stocks (DVM)
Undervalued Growth Stocks
Value Stocks, Under Radar (DVM)
Jim Slater's Zulu Principle (Discover Growth Stocks)
Relative Outperformance versus Industry over 1 Month
Strong Annual EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Affordable Stocks - Stocks with Good Trendlyne Valuation Score
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Top Gainers
Volume Shockers
Insiders bought stocks

Promoter decreasing their shareholding
Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Declining Net Cash Flow : Companies not able to generate net cash
Fall in Quarterly Revenue and Net Profit (YoY)
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding over the Past Two Months

Broker downgrades in price or recommendation in the past one month
MFs decreased their shareholding last quarter

Decline in Net Profit with falling Profit Margin (QoQ)

Natco Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats